![Janeen Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/07/2026
Ms. Janeen Doyle is a Chief Corporate & Business Development Officer at Janux Therapeutics, Inc. Ms. Doyle was previously employed as a Senior VP-Strategy & Business Development by Bristol Myers Squibb Co. and a Senior VP-Strategy & Business Development by Celgene Corp.
She received her undergraduate degree from Moravian College and an MBA from the University of Scranton.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC. 0,13 % | 02/06/2026 | 75.941 ( 0,13 % ) | 1 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Corporate Officer/Principal | 15/05/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Moravian College
 Moravian College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Scranton
 University of Scranton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
